Results 1 to 10 of about 221,445 (189)

Clopidogrel and Percutaneous Coronary Interventions [PDF]

JAMA, 2003
case fatality rates in inhaled anthrax can approach 100%. Anthrax bacteria, after being inhaled, use three toxins— protective antigen, oedema factor, and lethal factor—to enter, appropriate, and kill alveolar macrophages. Seven copies of protective antigen assemble and facilitate entry of oedema factor and lethal factor into macrophages.
Brian Y L, Wong, Eric A, Cohen
  +12 more sources

Percutaneous coronary intervention

Nippon Ronen Igakkai Zasshi. Japanese Journal of Geriatrics, 2018
Cardiac catheterization is a procedure by which information is obtained from the heart by passing fine plastic tubes (occasionally other instruments) either near to or within the heart, to introduce contrast to cardiac structures to understand their anatomy and function better, to measure pressures, and/or to measure oxygen saturations in different ...
Sam Dawkins, Cheerag Shirodaria
  +6 more sources

Imaging in Percutaneous Coronary Intervention

Reviews in Cardiovascular Medicine, 2022
Intracoronary imaging (ICI) use during percutaneous coronary intervention (PCI) has been shown to effectively improve cardiovascular outcomes, particularly for high-risk subgroups. However, data from randomized controlled trials are limited and the overall utilization rate of ICI remains variable between different countries and centers.
Mohan Satish, Anastasios Roumeliotis, David Power, Anton Camaj, Johny Nicolas, Daniel Feldman, Davis Jones, Keisuke Yasumura, Frans Beerkens, Saman Suleman, George Dangas   +10 more
openaire   +3 more sources

Bivalirudin in percutaneous coronary intervention [PDF]

Vascular Health and Risk Management, 2006
Bivalirudin is a member of the direct thrombin inhibitor group of anticoagulants. It has been evaluated as an alternative to unfractionated and low-molecular-weight heparins in the settings of percutaneous coronary intervention (PCI) and acute coronary syndrome (ACS). Results of clinical trials to date suggest bivalirudin is a viable alternative to the
Lehman, Sam, Chew, Derek Peng
openaire   +4 more sources

Guidelines for Percutaneous Coronary Interventions [PDF]

European Heart Journal, 2005
In patients with stable CAD, PCI can be considered a valuable initial mode of revascularization in all patients with objective large ischaemia in the presence of almost every lesion subset, with only one exception: chronic total occlusions that cannot be crossed. In early studies, there was a small survival advantage with CABG surgery compared with PCI
Silber, Sigmund, Albertsson, Per, Avilés, Francisco F., Camici, Paolo G., Colombo, Antonio, Hamm, Christian, Jørgensen, Erik, Marco, Jean, Nordrehaug, Jan-Erik, Ruzyllo, Witold, Urban, Philip, Stone, Gregg W., Wijns, William, Deckers, Jaap, Bassand, Jean-Pierre, Battler, Alexander, Bertrand, Michel, Betriu, Amadeo Gibert, Cokkinos, Dennis, Danchin, Nicolas, Di Mario, Carlo, de Feyter, Pim, Fox, Kim, Indolfi, Ciro, Karsch, Karl, Steg, Philippe Gabriel, Tendera, Michal, Van de Werf, Frans, Verheugt, Freek W. A., Widimski, Petr   +29 more
openaire   +5 more sources

Elevated Baseline Serum Fibrinogen: Effect on 2-Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention. [PDF]

, 2017
BackgroundElevated fibrinogen is associated with short-term major adverse cardiovascular events (MACE) after percutaneous coronary intervention, but the relation with late MACE is unknown.Methods and resultsBaseline demographics and 2-year MACE were ...
Ang, Lawrence, Behnamfar, Omid, Lin, Felice, Mahmud, Ehtisham, Palakodeti, Samhita, Patel, Mitul P, Pourdjabbar, Ali, Reeves, Ryan R   +7 more
core   +1 more source

Impact of incomplete percutaneous revascularization in patients With multivessel coronary artery disease: a systematic review and meta-analysis [PDF]

, 2016
Background: Up to half of patients undergoing percutaneous coronary intervention have multivessel coronary artery disease (MVD) with conflicting data regarding optimal revascularization strategy in such patients.
Bagur, Rodrigo, Berry, Colin, Curzen, Nick, De Belder, Mark, Kwok, Chun Shing, Large, Adrian, Ludman, Peter, Mamas, Mamas A., Matsukage, Takashi, Nagaraja, Vinayak, Nolan, James, Ooi, Sze-Yuan, Yoshimachi, Fuminobu   +12 more
core   +2 more sources

Collateral donor artery physiology and the influence of a chronic total occlusion on fractional flow reserve [PDF]

, 2015
Background— The presence of a concomitant chronic total coronary occlusion (CTO) and a large collateral contribution might alter the fractional flow reserve (FFR) of an interrogated vessel, rendering the FFR unreliable at predicting ischemia should the ...
Alahmar, A., Alahmar, Albert, Alamgir, F., Alamgir, Farquad, Cunnington, Michael S., Davies, Justin E., Hoye, Angela, Ladwiniec, A., Ladwiniec, Andrew, Mather, Adam N., Nijjer, Sukhjinder S., Oliver, Richard M., Rossington, J., Rossington, Jennifer, Thackray, S., Thackray, Simon   +15 more
core   +1 more source

Bilaterally symmetrical congenital absence of radial artery: a case report [PDF]

, 2014
BACKGROUND: The radial artery is used for the access of coronary angiography and percutaneous coronary intervention, as well as for coronary artery bypass surgery. Variations of upper limb arteries are common, however, congenital absence of radial artery
Jing-yuan Mao, Lei Shao, Ying Zheng
core   +1 more source

Novel patient-centered approach to facilitate same-day discharge in patients undergoing elective percutaneous coronary intervention [PDF]

, 2018
Background Same‐day discharge ( SDD ) after elective percutaneous coronary intervention is safe, less costly, and preferred by patients, but it is usually performed in low‐risk patients,
Amin, Amit P, Bach, Richard G, Caruso, Mary, Crimmins-Reda, Patricia, Dennis, Brandy, Kulkarni, Hemant, Kurz, Howard I, Lasala, John M, Miller, Samantha, Pendegraft, Marissa, Pierce, Andrew, Rahn, Brandon, Singh, Jasvindar, Sorensen, Katrine, Zajarias, Alan   +14 more
core   +2 more sources